Skip to main content
Fig. 7 | Cancer Nanotechnology

Fig. 7

From: A novel pH- and glutathione-responsive drug delivery system based on in situ growth of MOF199 on mesoporous organic silica nanoparticles targeting the hepatocellular carcinoma niche

Fig. 7

In vivo anti-tumor effects of drug-loaded nanocomposites. A Schematic illustration of this in vivo anti-tumor efficiency experiment. Tumor volume (B) and mice weight (C) were accurately measured every two days, * represents p < 0.05 and ** represents p < 0.01. D All mice were humanely killed when the tumor volume of the mice injected with PBS reached about 1500 mm3, PBS (a), MONs@MOF-199 (b), free DOX/SOR (c), D/S@MM (d), and D/S@SPMM (e). E survival rate

Back to article page